Abstract
Background
The present study was designed to review surgical outcomes for mycotic aneurysm of the aortic or iliac arteries at a single center.
Methods
The study was based on retrospective chart review of patients undergoing operation for mycotic aneurysm.
Results
From January 1998 to December 2007, 56 patients received surgical treatment for mycotic aneurysm of the aortic or iliac arteries. Aneurysm sites included the aortic arch (n = 5), proximal thoracic aorta (n = 4), distal thoracic aorta (n = 5), paravisceral aorta (n = 5), juxtarenal aorta (n = 4), infrarenal aorta (n = 30), and iliac arteries (n = 3). Salmonella was the leading pathogen (n = 34). Nineteen patients with suprarenal lesions underwent in situ prosthetic graft replacement (n = 17), extra-anatomic bypass (n = 1), or endovascular aneurysm repair (EVAR) (n = 1), and 37 patients with infrarenal lesions underwent the same procedures (n = 16, 20, and 1, respectively). Overall in-hospital mortality was 23%. After discharge, four patients (7%) developed reinfection that led to fatal sepsis. Graft infection developed after three in situ prosthetic grafts (9%) and one extra-anatomic bypass (5%). Patients with suprarenal aortic lesions had poorer in-hospital (34%) and late (16%) mortality rates than those with infrarenal lesions (p = 0.025). Those with suprarenal lesions also had a lower cumulative survival rate (p = 0.016).
Conclusions
The location of mycotic aneurysm was the determinant of mortality. Mycotic aneurysm of the suprarenal aorta has poor prognosis and requires alternative surgical treatment.
Similar content being viewed by others
References
Brown SL, Busuttil RW, Baker JD et al (1984) Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg 1:541–547
Wang JH, Liu YC, Yen MY et al (1996) Mycotic aneurysm due to non-typhi salmonella: report of 16 cases. Clin Infect Dis 23:743–747
Muller BT, Wegener OR, Grabitz K et al (2001) Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg 33:106–113
Oderich GS, Panneton JM, Bower TC et al (2001) Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg 34:900–908
Hsu R-B, Tsay Y-G, Wang S-S et al (2002) Surgical treatment for primary infected aneurysm of the descending thoracic aorta, abdominal aorta, and iliac arteries. J Vasc Surg 36:746–750
Luo C-Y, Ko W-C, Kan C-D et al (2003) In situ reconstruction of septic aortic pseudoaneurysm due to Salmonella or Streptococcus microbial aortitis: long-term follow-up. J Vasc Surg 38:975–982
Kyriakides C, Kan Y, Kerle M et al (2004) 11-year experience with anatomical and extra-anatomical repair of mycotic aortic aneurysms. Eur J Vasc Endovasc Surg 27:585–589
Ting AC, Cheng SW, Ho P et al (2005) Surgical treatment of infected aneurysms and pseudoaneurysms of the thoracic and abdominal aorta. Am J Surg 189:150–154
Woon CYL, Sebastian MG, Tay K-H et al (2008) Extra-anatomic revascularization and aortic exclusion for mycotic aneurysms of the infrarenal aorta and iliac arteries in an Asian population. Am J Surg 195:66–72
Dubois M, Daenens K, Houthoofd S et al (2010) Treatment of mycotic aneurysms with involvement of the abdominal aorta: single-centre experience in 44 consecutive cases. Eur J Vasc Endovasc Surg 40:450–456
Kwon TW, Kim HK, Moon KM et al (2010) In situ polytetrafluoroethylene graft bypass for primary infected aneurysm of the infrarenal abdominal aorta. World J Surg 34:1689–1695. doi:10.1007/s00268-010-0507-3
Hsu RB, Chen RJ, Wang SS et al (2004) Infected aortic aneurysms: clinical outcome and risk factor analysis. J Vasc Surg 40:30–35
Taylor LM Jr, Deitz DM, McConnell DB et al (1988) Treatment of infected abdominal aneurysms by extraanatomic bypass, aneurysm excision, and drainage. Am J Surg 155:655–658
Soravia-Dunand VA, Loo VG, Salit IE (1999) Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis 29:862–868
Johansen K, Devin J (1983) Mycotic aortic aneurysms. A reappraisal. Arch Surg 118:583–588
Sessa C, Farah I, Voirin L et al (1997) Infected aneurysms of the infrarenal abdominal aorta: diagnostic criteria and therapeutic strategy. Ann Vasc Surg 11:453–463
Jarrett F, Darling RC, Mundth ED et al (1975) Experience with infected aneurysms of the abdominal aorta. Arch Surg 110:1281–1286
Fernandez Guerrero ML, Aguado JM, Arribas A et al (2004) The spectrum of cardiovascular infections due to Salmonella enterica: a review of clinical features and factors determining outcome. Medicine (Baltimore) 83:123–138
Hsu RB, Lin FY (2005) Risk factors for bacteraemia and endovascular infection due to non-typhoid salmonella: a reappraisal. QJM 98:821–827
Zhou W, Lin PH, Bush RL et al (2006) In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections: a multi-institutional experience. Tex Heart Inst J 33:14–18
Brown KE, Heyer K, Rodriguez H et al (2009) Arterial reconstruction with cryopreserved human allografts in the setting of infection: a single-center experience with midterm follow-up. J Vasc Surg 49:660–666
Benjamin ME, Cohn EJ Jr, Purtill WA et al (1999) Arterial reconstruction with deep leg veins for the treatment of mycotic aneurysms. J Vasc Surg 30:1004–1015
Ehsan O, Gibbons CP (2009) A 10-year experience of using femoro-popliteal vein for re-vascularisation in graft and arterial infections. Eur J Vasc Endovasc Surg 38:172–179
Hsu RB, Tsay YG, Wang SS et al (2003) Management of aortic aneurysm infected with Salmonella. Br J Surg 90:1080–1084
Hsu R-B, Lin F-Y (2007) Surgery for infected aneurysm of the aortic arch. J Thorac Cardiovasc Surg 134:1157–1162
Hsu R-B, Lin F-Y (2008) Infected aneurysm of the thoracic aorta. J Vasc Surg 47:270–276
Fillmore AJ, Valentine RJ (2003) Surgical mortality in patients with infected aortic aneurysms. J Am Coll Surg 196:435–441
Ihaya A, Chiba Y, Kimura T et al (2001) Surgical outcome of infectious aneurysm of the abdominal aorta with or without SIRS. Cardiovasc Surg 9:436–440
Greenhalgh RM, Brown LC, Kwong GP et al (2004) Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet 364:843–848
Matsumura JS, Cambria RP, Dake MD et al (2008) International controlled clinical trial of thoracic endovascular aneurysm repair with the Zenith TX2 endovascular graft: 1-year results. J Vasc Surg 47:247–257 (discussion 257)
Kan CD, Lee HL, Yang YJ (2007) Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg 46:906–912
Razavi MK, Razavi MD (2008) Stent-graft treatment of mycotic aneurysms: a review of the current literature. J Vasc Interv Radiol 19:S51–S56
Clough RE, Black SA, Lyons OT et al (2009) Is endovascular repair of mycotic aortic aneurysms a durable treatment option? Eur J Vasc Endovasc Surg 37:407–412
Sorelius K, Mani K, Bjorck M et al (2009) Endovascular repair of mycotic aortic aneurysms. J Vasc Surg 50:269–274
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, SY., Hsieh, HC., Ko, PJ. et al. Surgical Outcome for Mycotic Aortic and Iliac Anuerysm. World J Surg 35, 1671–1678 (2011). https://doi.org/10.1007/s00268-011-1104-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-011-1104-9